PMV Pharmaceuticals (PMVP) Change in Cash (2019 - 2026)

PMV Pharmaceuticals (PMVP) has 8 years of Change in Cash data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Change in Cash fell 89.04% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.2 million (down 526.21% YoY) and the FY2025 annual result came in at -$2.9 million, down 223.21% from the prior year.
• Change in Cash slipped to $1.1 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $34.6 million in Q1 2023 to a low of -$74.7 million in Q2 2023.
• A 5-year average of -$7.9 million and a median of $284000.0 in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash jumped 302.37% — and 2025, when it plunged 2842.96%.
• Tracing PMVP's Change in Cash over 5 years: stood at $8.4 million in 2022, then tumbled by 269.89% to -$14.4 million in 2023, then jumped by 38.99% to -$8.8 million in 2024, then soared by 118.8% to $1.6 million in 2025, then plunged by 30.32% to $1.1 million in 2026.
• The last three Change in Cash figures came in at $1.1 million (Q1 2026), $1.6 million (Q4 2025), and -$7.8 million (Q3 2025), per Business Quant data.